Takeda (TOKYO:4502/NYSE:TAK) today announced earnings results for the third quarter of fiscal year 2025 (nine months ended December 31, 2025). The gap between incremental Growth & Launch Products revenue and VYVANSE erosion is narrowing, and operational efficiencies drove year-on-year reductions in operating expenses, including R&D. The company raised its full-year forecasts based on cost discipline and FX tailwind, while its Revenue Management Guidance has been updated primarily due to...
Multi-Color Corporation (“MCC” or the “Company”), a global leader in prime label solutions, today announced that to implement the previously announced restructuring support agreement (the “RSA”), the Company has commenced its prepackaged Chapter 11 filing in the United States Bankruptcy Court for the District of New Jersey (“the Court”). MCC announced on January 27 it had entered into the RSA with holders of approximately 72% in amount of MCC’s secured first lien debt and its equity sponsor, ...
Robbyant, an embodied AI company within Ant Group, today announced the open-source release of LingBot-World, a world model that achieves industry-leading performance in video quality, dynamic fidelity, long-term consistency, and interactivity. Designed for embodied intelligence, autonomous driving, and game development, LingBot-World offers a high-fidelity, highly dynamic, and real-time controllable “digital sandbox” for simulation and training. This press release features multimedia. View the...
The strategies that sustained organisations through recent years will no longer be sufficient in 2026, according to a new report launched today by Top Employers Institute, a leading certification, benchmarking and advisory firm. Speed and scale, as default responses to pressure, have reached their limits. What will fuel high-performing organisations in the year ahead will be designing work, leadership and management systems with deliberate intent. World of Work Trends 2026: The Intentional Or...
News organisations gather in Paris to collaborate on securing media provenance
It has never been more important to safeguard authentic news media, say the organisers.
Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat® KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for p...